Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons.
about
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia.The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury.Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4PPARs: a new target for neuroprotection.The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones.Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats.Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.
P2860
Q33818388-8E5132B9-E593-4965-AB4A-B42365BC42F9Q35101529-D516945B-E023-4BBE-851E-F6D69A385040Q36904879-2FECA022-18D2-4844-8DF2-ECDF3BA85BF2Q37335663-BD821979-B3D7-40B2-82B7-8D6A658525B1Q39317818-F67C7E71-096C-41DE-860E-E0BF4EB9B189Q41148387-256141BA-16EF-4AF2-8764-A309535B0A1EQ42410542-0D94B0E5-9B5B-4D9E-AA59-6D50E5B29A9CQ42718625-0B0A8BC4-2110-4515-B9E5-68B2E8FDADB0Q44663222-A57F7D41-0458-4C61-A49F-BBC11D018CDFQ46927529-9F683362-E9E2-446C-9DC0-C9ADD0266D99Q46970970-92D34C47-603B-4C60-A941-02F8C744EAEDQ48034616-2F2D25C8-65A2-4CF4-80E9-F3D15CAF2E08Q48176203-D5E16C80-B829-4267-9AF9-8FD08B3DF4F9Q48362500-A5F80CF4-EC13-4D84-B868-E219FA974413Q48396522-5E139584-ABC2-44A5-A403-A5189B690E98Q48617615-05DE85AA-68C0-439E-B14B-6EA10572FE13Q48901148-5E9DB7D7-4A97-4269-86E5-5493C2211BD2
P2860
Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@en
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@nl
type
label
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@en
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@nl
prefLabel
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@en
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@nl
P2093
P1433
P1476
Troglitazone inhibits both pos ...... in cerebellar granule neurons.
@en
P2093
Jun Harada
Marie Hisamoto
Shigeko Uryu
Tomiichiro Oda
P304
P356
10.1016/S0006-8993(01)03242-5
P407
P577
2002-01-01T00:00:00Z